Frontiers in Pharmacology (Jun 2020)
Corrigendum: USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway
- Sudong Xue,
- Wei Wu,
- Ziyan Wang,
- Guangxian Lu,
- Jiantong Sun,
- Xing Jin,
- Linjun Xie,
- Xiaoyu Wang,
- Caihong Tan,
- Zheng Wang,
- Wenjuan Wang,
- Xinyuan Ding
Affiliations
- Sudong Xue
- Department of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
- Wei Wu
- Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China
- Ziyan Wang
- Department of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
- Guangxian Lu
- Department of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
- Jiantong Sun
- Department of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
- Xing Jin
- Department of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
- Linjun Xie
- Department of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
- Xiaoyu Wang
- Department of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
- Caihong Tan
- Department of Pharmacy, The Affiliated Hospital of Jiangsu University, Zhenjiang, China
- Zheng Wang
- Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Wenjuan Wang
- Department of Pharmacy, The Children's Hospital of Soochow University, Suzhou, China
- Xinyuan Ding
- Department of Pharmacy, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
- DOI
- https://doi.org/10.3389/fphar.2020.00948
- Journal volume & issue
-
Vol. 11
Abstract
No abstracts available.Keywords
- non-small cell lung cancer
- metastasis
- epithelial-to-mesenchymal transition
- ubiquitin-specific protease 5 (USP5)
- β-catenin
